The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya

Εμφάνιση άλλων εκδόσεων (1)

Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Amin, A, Zurovac, D, Kangwana, B, Greeenfield, J, Otieno, D, Akhwale, W, Snow, R
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	BioMed Central 2007
Θέματα:	Malaria Tropical medicine Infectious diseases

Παρόμοια τεκμήρια

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
ανά: Amin, A, κ.ά.
Έκδοση: (2007)

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
ανά: Otieno Dorothy N, κ.ά.
Έκδοση: (2007-05-01)

The decline in paediatric malaria admissions on the coast of Kenya
ανά: Okiro, E, κ.ά.
Έκδοση: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
ανά: Zurovac, D, κ.ά.
Έκδοση: (2007)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
ανά: Wasunna, B, κ.ά.
Έκδοση: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
ανά: Sipilanyambe, N, κ.ά.
Έκδοση: (2008)

Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector
ανά: Amin, A, κ.ά.
Έκδοση: (2005)

Malaria early warning in Kenya
ανά: Hay, S, κ.ά.
Έκδοση: (2001)

Evidence for over-dispersion in the distribution of clinical malaria episodes in children
ανά: Mwangi, T, κ.ά.
Έκδοση: (2008)

Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya
ανά: Noor, A, κ.ά.
Έκδοση: (2003)

Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project
ανά: Guerra, C, κ.ά.
Έκδοση: (2007)

Distribution of the main malaria vectors in Kenya
ανά: Okara, R, κ.ά.
Έκδοση: (2010)

The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya
ανά: Atkinson, S, κ.ά.
Έκδοση: (2007)

The risks of malaria infection in Kenya in 2009
ανά: Noor, A, κ.ά.
Έκδοση: (2009)

Molecular pathological investigation of the pathophysiology of fatal malaria
ανά: Prapansilp, P
Έκδοση: (2012)

Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya
ανά: Gikandi, P, κ.ά.
Έκδοση: (2008)

Artemisinin antimalarials: preserving the "magic bullet"
ανά: Maude, R, κ.ά.
Έκδοση: (2010)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
ανά: Zurovac, D, κ.ά.
Έκδοση: (2008)

The Activity of Mixed Microalgae Polysaccharides from Indonesia as Anti-Malaria in Vitro
ανά: Mahendra Pujiyanto, κ.ά.
Έκδοση: (2022-08-01)

The relationship between the Plasmodium falciparum parasite ratio in childhood and climate estimates of malaria transmission in Kenya
ανά: Omumbo, J, κ.ά.
Έκδοση: (2004)

Standardizing estimates of the Plasmodium falciparum parasite rate
ανά: Smith, D, κ.ά.
Έκδοση: (2007)

Morbidity and mortality due to Plasmodium vivax malaria in Papua, Indonesia and its control using antimalarial drugs
ανά: Douglas, N
Έκδοση: (2011)

The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren
ανά: Brooker, S, κ.ά.
Έκδοση: (2006)

Increasing coverage and decreasing inequity in insecticide-treated bed net use among rural Kenyan children
ανά: Noor, A, κ.ά.
Έκδοση: (2007)

Plasmodium infection and its risk factors in eastern Uganda
ανά: Pullan, R, κ.ά.
Έκδοση: (2010)

Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
ανά: Kloprogge, F
Έκδοση: (2013)

Ranking of elimination feasibility between malaria-endemic countries
ανά: Tatem, A, κ.ά.
Έκδοση: (2010)

Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
ανά: Njogu, J, κ.ά.
Έκδοση: (2008)

Barriers to prompt and effective malaria treatment among the poorest population in Kenya
ανά: Chuma, J, κ.ά.
Έκδοση: (2010)

The uncertain burden of Plasmodium falciparum epidemics in Africa
ανά: Cox, J, κ.ά.
Έκδοση: (2007)

Malaria in Africa: progress and prospects in the decade since the Abuja Declaration
ανά: Snow, R, κ.ά.
Έκδοση: (2010)

An immune basis for malaria protection by the sickle cell trait
ανά: Williams, T, κ.ά.
Έκδοση: (2005)

Information for decision making from imperfect national data: tracking major changes in health care use in Kenya using geostatistics
ανά: Gething, P, κ.ά.
Έκδοση: (2007)

Revisiting the basic reproductive number for malaria and its implications for malaria control
ανά: Smith, D, κ.ά.
Έκδοση: (2007)

Wealth, mother's education and physical access as determinants of retail sector net use in rural Kenya
ανά: Noor, A, κ.ά.
Έκδοση: (2006)

Mapping the global extent of malaria in 2005
ανά: Guerra, C, κ.ά.
Έκδοση: (2006)

Strategies for improving radical cure in P. vivax malaria
ανά: John, G
Έκδοση: (2012)

The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
ανά: Zurovac, D, κ.ά.
Έκδοση: (2006)

Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
ανά: Pongtavornpinyo, W, κ.ά.
Έκδοση: (2008)

Measuring malaria endemicity from intense to interrupted transmission
ανά: Hay, S, κ.ά.
Έκδοση: (2008)